α-Lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants

FEBS Letters

Volumn 394, Issue 1, 1996, Pages 9-13

  Merin, Jocelyn P ^a   Matsuyama, Mototaka ^a   Kira, Toshihiko ^b   Baba, Masanori ^c   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

AIDS; Gene expression; HIV 1; N Acetylcysteine; Nuclear factor B; Reactive oxygen intermediate; Lipoic acid

Indexed keywords

ACETYLCYSTEINE; HYGROMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MACROPHAGE; PLASMID; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030599164     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)00919-2     Document Type: Article

References (24)

1. [1] Fuchs, J., Schofer, H., Milbradt, R., Freisleben, H.J., Buhl, R., Siems, W. and Grune, T. (1993) Arzneimittelforschung 43, 1359-1362.
2. [2] Faust, A., Burkart, V., Ulrich, H., Weischer, C.H. and Kolb, H. (1994) Int. J. Immunopharmacol. 16, 61-66.
3. [3] Ou, P., Trischler, H.J. and Wolff, S.P. (1995) Biochem. Pharmacol. 50, 123-126.
4. [4] Han, D., Trischler, H.J. and Packer, L. (1995) Biochem. and Biophys. Res. Comm. 207, 258-264.
5. [5] Fuchs, J. and Milbradt, R. (1994) Skin Pharmacol. 7, 278-284.
6. [6] Greenmyre, J.T., Garcia-Osuna, M. and Greene, J.G. (1994) Neurosci. Lett. 171, 17-20.
7. [7] Constantinescu, A., Tritschler, H. and Packer, L. (1994) Biochem. Mol. Biol. Int. 33, 669-679.
8. [8] Matsugo, S., Yan, L-J., Trischler, H.J. and Packer, L. (1995) Biochem. and Biophys. Res. Commun. 208, 161-167.
9. [9] Scott, B.C., Aruoma, O.I., Evans, P.J., O'Neill, C., Van der Vliet, A., Cross, C.E., Tritschler, H. and Halliwell, B. (1994) Free Radic. Res. 20, 119-133.
10. [10] Karg, E., Tunek, A., Brotell, H., Rosengren, E. and Rorsman, H. (1990) Pigment Cell Res. 3, 11-15.
11. [11] Kalebic, T., Kinter, A., Poli, G., Anderson, M.E., Meister, A. and Fauci, A. (1991) Proc. Natl, Acad. Sci. USA 88, 986-990.
12. [12] Staal, F.J.T., Roederer, M., Herzenberg, L.A. and Herzenberg, L.A. (1990) Proc. Natl. Acad. Sci. USA 87, 9943-9947.
13. [13] Okamoto, T. (1995) in: Anti-AIDS Drug Development Challenges, Strategies and Prospects (Mohan, P. and Baba, M. eds.) pp. 117-127.
14. [14] Staal, F.J.T., Anderson, M.T. and Herzenberg, L.A. (1995) Methods in Enzymol. 252, 168-174.
15. [15] Hayashi, T., Ueno, Y. and Okamoto, T. (1993) J. Biol. Chem. 268, 11380-11388.
16. [16] Suzuki, Y.J., Aggarwal, B.B. and Packer, L. (1992) Biochem. and Biophys. Res. Commun. 189, 1709-1715.
17. [17] Meyer, M., Schreck, R. and Baeurle, P.A. (1993) EMBO J. 12, 2005-2015.
18. [18] Mosmann, T. (1983) J. Immunol. Methods 65, 55-63.
19. [19] Kira, T., Merin, J.P., Baba, M., Shigeta, S. and Okamoto, T. (1995) AIDS Res. Hum. Retrovir. 11, 1359-1366.
20. [20] Butera, S.T., Perez, V.L., Wu, B.Y., Nabel, G.J. and Folks, T.M. (1991) J. Virol. 65, 4645-4653.
21. [21] Okamoto, T., Matsuyama, T., Mori, S., Hamamoto, Y., Kobayashi, N., Yamamoto, N., Josephs, S.F., Wong-Staal, F. and Shimotohno, K. (1989) AIDS Res. Hum. Retrovir. 5. 131-138.
22. [22] Osborn, L., Kunkel, S. and Nabel, G.J. (1989) Proc. Natl. Acad. Sci. USA 86, 2336-2340.
23. [23] Duh, E.J., Maury, W.J., Folks, T.M., Fauci, A.S. and Rabson, A.B. (1989) Proc. Natl. Acad. Sci. USA 86, 5974-5978.
24. [24] Baur, A., Harrer, T., Peukert, M., Jahn, G., Kalden, J.R. and Fleckenstein, B. (1991) Klin. Wochenschr. 69, 722-724.